Navigation Links
Recovery Act funds expand studies of stem cell biology
Date:10/28/2009

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

In theory, iPS cells could generate any type of cell and be used to treat diseases. But to realize this potential, scientists need a much better understanding of iPS cells' fundamental properties and how to efficiently derive cells that are safe for therapeutic uses.

To speed iPS research, NIGMS has awarded one-year grant supplements to 22 scientists at 16 institutions in 12 states and the District of Columbia. The investigators already have strong records of accomplishment in a range of research areas and will study iPS cells in varied biological systems.

"Stem cell biology is poised for rapid advances, and we expect our Recovery Act investment to have a catalytic effect. The new awards will contribute to the field's progress by enhancing the utility of iPS cells as tools for research, for testing the effects of drugs on human tissues and ultimately for patient-specific treatments," said NIGMS Director Jeremy M. Berg, Ph.D.

The Recovery Act funding will allow the scientists to address such important questions as:

  • How does reprogramming work?
  • What factors are necessary to create iPS cells efficiently and safely?
  • What drives iPS cells toward a desired cell type that can be used to regenerate or repair damaged tissues in a patient?
  • Do iPS cells differ from embryonic and adult stem cells, and if so, how?

The investigators receiving supplements are:

  • Bruce Beutler, Scripps Research Institute, La Jolla, Calif.
  • C. Anthony Blau, University of Washington, Seattle
  • Richard Cerione, Cornell University, Ithaca, N.Y.
  • Stephen Dalton, University of Georgia, Athens
  • Sharon Dent, University of Texas M.D. Anderson Cancer Center, Houston
  • Andres Garcia, Georgia Institute of Technology, Atlanta
  • David Gilbert, Florida State University, Tallahassee
  • Margaret Goodell, Baylor College of Medicine, Houston
  • Brenton Graveley, University of Connecticut Health Center, Farmington
  • Jeanne Lawrence, University of Massachusetts Medical School, Worcester
  • Jeannie Lee, Massachusetts General Hospital, Boston
  • Shaohua Li, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway
  • John Lis, Cornell University, Ithaca, N.Y.
  • Nancy Maizels, University of Washington, Seattle
  • Sergie Nekhai, Howard University, Washington, D.C.
  • Sean Palecek, University of Wisconsin-Madison
  • Arnold Rizzino, University of Nebraska Medical Center, Omaha
  • Hannele Ruohola-Baker, University of Washington, Seattle
  • James Thomson, University of Wisconsin-Madison
  • Yi Wang, Baylor College of Medicine, Houston
  • Jeffrey Wilusz, Colorado State University, Fort Collins
  • Jerome Zack, University of California, Los Angeles


'/>"/>

Contact: Ann Dieffenbach
dieffena@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert  

Related biology news :

1. Survey finds elevated rates of new asthma among WTC rescue and recovery workers
2. New study shows greenback cutthroat trout involved in recovery effort misidentified
3. Recovery from acid rain much slower than expected
4. Diet and lifestyle critical to recovery, says study
5. Ozone hole recovery may reshape southern hemisphere climate change
6. Recovery efforts not enough for critically endangered Asian vulture
7. Diversity of plant-eating fishes may be key to recovery of coral reefs
8. Endangered sawfish focus of national collection and recovery efforts
9. Flowering plants speed post-surgery recovery
10. Long-term recovery of reefs from bleaching requires local action to increase resilience
11. Basic research critical to Americas economic recovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recovery Act funds expand studies of stem cell biology
(Date:12/5/2016)...  The Office of Justice Programs, National Institute ... Enhance or Replace Medico Legal Autopsies?" on NIJ.gov.  ... replacing forensic autopsies with postmortem X-ray computed tomography, ... response to recommendations made by The National Academy ... as a potential component of medicolegal death investigations. ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... Opal Kelly, ... essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the company's ... is a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM socket ...
(Date:12/8/2016)... ... 2016 , ... KBioBox llc announced today the launch of ... a sophisticated “3 click” gene dditing off target analysis program and a “3 ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical researchers ...
(Date:12/8/2016)... 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing and commercializing products to treat rare diseases ... today the long-term follow-up data from its Phase ... Innate Defense Regulator (IDR), in the treatment of ... patients undergoing chemoradiation therapy (CRT).  The additional 12-month ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. Ltd. ... KRW (US $18.9M) Series A financing. This financing round ... Tech Venture and SNU Bio Angel. This new funding ... billion KRW (US $27.7M) since its founding in 2015. ... bolster the development and commercialization of its immuno-oncology programs, ...
Breaking Biology Technology: